Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon. It causes ulcers, or open sores, in the colon’s lining, leading to symptoms like diarrhea, bleeding,…
Join Elisa K. Boden, MD, Ryan Ungaro, MD, and patient advocate Nathan Marohn in this insightful social media event, “The Intersection of Histologic, Endoscopic, and Symptomatic Remission in…
NEW YORK (Reuters Health) – Gastric acid suppression by proton pump inhibitors (PPIs) is associated with an increased risk of Clostridium difficile-related diarrhea in hospitalized patients, results of…
NEW YORK (Reuters Health) – Men who gain weight during adulthood – even those who are not considered to be overweight according to their body mass index –…
NEW YORK (Reuters Health) – The diagnosis of colorectal cancer will be delayed or missed in a substantial number of patients with inflammatory bowel disease (IBD) if colonoscopic…
NEW YORK (Reuters Health) – Children who develop Crohn’s disease before the age of five years have a less complicated disease course than children with disease onset after…
Partnership to Fight Chronic Disease is a national coalition of patients, providers, community organizations, business and labor groups and health policy experts, committed to raising awareness of policies…
A 50-week, placebo-controlled trial shows that combining infliximab and methotrexate provides no extra benefit in treating Crohn’s disease. References and Resources Feagan B. A randomized trial of methotrexate…
The FDA has approved natalizumab (Tysabri) for the treatment of moderate-to-severe Crohn’s disease in patients with evidence of inflammation who have had an inadequate response to, or are…
